NasdaqCM - Nasdaq Real Time Price USD
Celldex Therapeutics, Inc. (CLDX)
19.40
-0.03
(-0.14%)
As of 9:51:50 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 209.11k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MARINO JAMES J Director | Stock Gift at price 0.00 per share. | Direct | 0 | Nov 18, 2024 |
| CROWLEY ELIZABETH Officer | Conversion of Exercise of derivative security at price 10.38 per share. | Direct | 311,400 | Jun 14, 2024 |
| MARTIN SAMUEL BATES Chief Financial Officer | Conversion of Exercise of derivative security at price 9.02 - 10.38 per share. | Direct | 204,990 | Jun 14, 2024 |
| CROWLEY ELIZABETH Officer | Sale at price 34.87 per share. | Direct | 1,045,962 | Jun 14, 2024 |
| MARTIN SAMUEL BATES Chief Financial Officer | Sale at price 35.42 per share. | Direct | 608,315 | Jun 14, 2024 |
| YOUNG DIANE C Officer | Conversion of Exercise of derivative security at price 2.71 per share. | Direct | 40,650 | Jun 11, 2024 |
| CROWLEY ELIZABETH Officer | Conversion of Exercise of derivative security at price 9.02 - 10.38 per share. | Direct | 145,474 | Jun 7, 2024 |
| YOUNG DIANE C Officer | Sale at price 35.26 per share. | Direct | 1,586,844 | Jun 7, 2024 |
| CROWLEY ELIZABETH Officer | Sale at price 35.06 per share. | Direct | 525,873 | Jun 7, 2024 |
| JIMENEZ FREDDY A General Counsel | Conversion of Exercise of derivative security at price 10.38 per share. | Direct | 99,025 | Jun 5, 2024 |
| WRIGHT RICHARD M Officer | Conversion of Exercise of derivative security at price 2.78 - 28.00 per share. | Direct | 1,267,540 | Jun 3, 2024 |
| HEATH-CHIOZZI MARGO Officer | Conversion of Exercise of derivative security at price 9.02 - 10.38 per share. | Direct | 662,575 | Jun 3, 2024 |
| JIMENEZ FREDDY A General Counsel | Conversion of Exercise of derivative security at price 10.38 per share. | Direct | 83,102 | Jun 3, 2024 |
| WRIGHT RICHARD M Officer | Sale at price 33.53 - 33.99 per share. | Direct | 1,579,353 | Jun 3, 2024 |
| HEATH-CHIOZZI MARGO Officer | Sale at price 33.65 per share. | Direct | 1,964,088 | Jun 3, 2024 |
| JIMENEZ FREDDY A General Counsel | Sale at price 33.60 per share. | Direct | 269,002 | Jun 3, 2024 |
| CROWLEY ELIZABETH Officer | Conversion of Exercise of derivative security at price 2.78 - 9.02 per share. | Direct | 172,397 | May 30, 2024 |
| CAVANAUGH SARAH Officer | Conversion of Exercise of derivative security at price 2.78 - 9.02 per share. | Direct | 120,979 | May 30, 2024 |
| MARTIN SAMUEL BATES Chief Financial Officer | Conversion of Exercise of derivative security at price 10.38 per share. | Direct | 259,500 | May 30, 2024 |
| HEATH-CHIOZZI MARGO Officer | Conversion of Exercise of derivative security at price 2.78 - 10.38 per share. | Direct | 126,301 | May 30, 2024 |
| CROWLEY ELIZABETH Officer | Sale at price 33.64 per share. | Direct | 1,298,384 | May 30, 2024 |
| CAVANAUGH SARAH Officer | Sale at price 33.73 per share. | Direct | 703,334 | May 30, 2024 |
| MARTIN SAMUEL BATES Chief Financial Officer | Sale at price 34.05 per share. | Direct | 1,191,774 | May 30, 2024 |
| HEATH-CHIOZZI MARGO Officer | Sale at price 34.07 per share. | Direct | 1,319,156 | May 30, 2024 |
| JIMENEZ FREDDY A General Counsel | Conversion of Exercise of derivative security at price 2.78 - 9.02 per share. | Direct | 93,163 | Feb 13, 2024 |
| MARTIN SAMUEL BATES Chief Financial Officer | Conversion of Exercise of derivative security at price 2.78 per share. | Direct | 29,885 | Jan 2, 2024 |
Related Tickers
FOLD Amicus Therapeutics, Inc.
7.07
-0.36%
IMUC EOM Pharmaceuticals Holdings, Inc.
0.1390
0.00%
ACAD ACADIA Pharmaceuticals Inc.
14.53
-0.62%
SNDX Syndax Pharmaceuticals, Inc.
13.14
+1.08%
BCYC Bicycle Therapeutics plc
8.49
-2.06%
PTGX Protagonist Therapeutics, Inc.
45.63
-1.16%
KPTI Karyopharm Therapeutics Inc.
6.30
+0.48%
CYTK Cytokinetics, Incorporated
38.62
+1.62%
AKRO Akero Therapeutics, Inc.
39.79
+0.44%
INCY Incyte Corporation
57.79
-0.37%